We specialise in breathalysers and since the acquisition of Elitista AB education around metabolism. Our solution, personal health data paired with education, provides users with powerful tools to improve their own health. The new funds will primarily be used to scale up sales of Acetrack and Elitista services in Sweden and in Europe.

"With the help of the additional capital, we can continue with the commenced expansion in Europe and also meet the demand in new markets," says Anders Murman, CEO.